ArticleNeuropsychiatric disease and treatment2026
Association Between Triglyceride-Glucose Index and Hyperuricemia in Hospitalized Patients with Depression: A Cross-Sectional Study.
Article in Neuropsychiatric disease and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to investigate the association between the triglyceride-glucose (TyG) index and hyperuricemia (HUA) in hospitalized patients with depression and to explore subgroup heterogeneity, thus providing evidence for early prevention and management of HUA in this population. Methods: A retrospective cross-sectional study was conducted on 3196 hospitalized patients with depression (aged ≥ 18 years) admitted to the Affiliated Mental Hospital of Anhui Medical University between May 2022 and June 2024. HUA was defined as serum uric acid (SUA) > 420 μmol/L in men and > 360 μmol/L in women. After assessing multicollinearity using variance inflation factors (VIF), we performed hierarchical multivariable logistic regression to examine the association between the TyG index and HUA. Restricted cubic spline (RCS) analysis and quartile grouping were used to explore the dose-response relationship. Subgroup analyses were conducted to investigate potential heterogeneity. Results: The overall prevalence of HUA was 11.5% (16.0% in men and 9.5% in women). After adjusting for potential confounders, the TyG index was significantly associated with HUA risk (OR = 1.76, 95% CI: 1.37-2.25, p < 0.001). RCS analysis revealed a positive dose-response relationship between the TyG index and HUA risk, with an accelerated increase observed when the TyG index exceeded 9. A TyG index ≥ 9 was identified as a potential risk threshold. Conclusion: The TyG index is an independent risk factor for HUA in hospitalized patients with depression. Incorporating the TyG index into metabolic risk assessment may facilitate early identification and intervention of HUA in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.